Navigation Links
ARIUS announces second quarter fiscal 2008 financial results
Date:7/11/2008

nts, short-term investments and net working capital of $5,635,365, $6,825,190 and $9,088,712, respectively. The Company currently believes that it has adequate financial resources to continue into the fourth quarter of fiscal 2008 based on planned research and development expenditures and operating costs.

About ARIUS

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 500 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies. ARIUS is listed on the TSX under the symbol "ARI". For further information, visit http://www.ariusmabs.com

Financial Information to Follow:

ARIUS RESEARCH INC.

(A DEVELOPMENT STAGE COMPANY)

INTERIM BALANCE SHEETS

(Unaudited)

-------------------------------------------------------------------------

May 31, November 30,

2008 2007

$ $

-------------------------------------------------------------------------

Assets

Current assets:

Cash and cash equivalents 8,543,124 5,635,365

Short-term investments - 6,825,190

Receivables 185,672 230,126

Refundable tax credits 600,000 400,000

Prepaid expenses
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ARIUS presents new findings for anti-cancer antibody programs at AACR
2. ARIUS announces first quarter fiscal 2008 financial results
3. ARIUS 2008 Annual and Special Meeting of Shareholders
4. ARIUS recognized for entrepreneurial excellence
5. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
6. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
7. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
8. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
9. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
10. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
11. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 Fast, semi-automatic creation ... in documents ChemAxon , a ... services for life science research, launches ChemCurator, an ... structures from documents. Markush structures are ... generating and understanding Markush structures is a difficult ...
(Date:9/30/2014)... , Sept. 30, 2014  KemPharm, Inc., ... discovery and development of proprietary new molecular entity ... Patent and Trademark Office (USPTO) issued U.S. Patent ... entitled, "Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl ... Making and Use Thereof." The patent, ...
(Date:9/30/2014)... September 30, 2014 iLab Solutions announced ... Benchmarking study which focuses on core facility operations, ... core managers face today. , In its 4th year ... of note is the year-over-year decrease in the percentage ... appear to be feeling the constraints of this trend. ...
(Date:9/30/2014)... CT (PRWEB) September 30, 2014 ... non-profit funder of Lyme disease research at universities, today ... researchers focused on the identification, treatment and cure for ... it had received the most applications in its history—over ... , “While we were pleased to receive so ...
Breaking Biology Technology:ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 4
... May 27 CellCyte Genetics,Corporation (CellCyte) (OTC ... provide shareholders, potential investors and journalists,with accurate ... Room powered Web site: http://www.cellcyte.com ... or sources for stories from,CellCyte can access ...
... that the application,form for the 2008 Protein Tomography(TM) ... application will be offered a Protein Tomography(TM),study in ... in the range of 0.1 and 0.5 million ... http://www.newscom.com/cgi-bin/prnh/20080220/294289 ), The Protein Tomography(TM) ...
... Online Tool Helps Pair Dialysis Patients with Compatible ... DaVita Inc., a leading,provider of kidney care ... disease (CKD), recently introduced "Treatment Evaluator", an,interactive online ... modalities DaVita(R) offers, and encourage patients to engage ...
Cached Biology Technology:The Protein Tomography(TM) Award Now Published on Sidec's Homepage 2DaVita Introduces 'Treatment Evaluator' 2
(Date:9/29/2014)... Parents with children at home should use ventilation when ... University are recommending, after a new study showed an ... symptoms and chronic bronchitis. , "In homes where a ... asthma and wheezing is higher than in homes where ... Smit, an associate professor in the College of Public ...
(Date:9/29/2014)... a bad rap, and understandably so. The grain-of-rice-sized insects ... millions of acres in the Western U.S. and Canada ... popular belief, these pests may not be to blame ... swept through the region. Instead, weather and topography play ... than these bark-boring beetles. , New research led by ...
(Date:9/29/2014)... Manuel Santos has presented Dr. Cristin Samper, president ... the prestigious Order of San Carlos. , The ... civilians and military officers who have made outstanding ... of international relations. , An international authority on ... invited to the Colombian Residence in New York ...
Breaking Biology News(10 mins):Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 3Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 2Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 3Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 4
... 2012) The latest conference to be sponsored ... the molecular mechanisms involved in exercise-mediated physiological changes ... dynamic molecular and cellular pathways. Entitled Integrative Biology ... October 10-13, 2012 in Westminster, Colorado. The full ...
... million to Emory University,s Center for Selective C-H Functionalization, ... the country working to revolutionize the field of organic ... a huge impact on the development of new drugs ... organic synthesis, and making it faster, simpler and greener," ...
... Environment Initiative (E2I), a sweeping plan to support interdisciplinary ... the university to work with Houston,s energy industry to ... current and alternative forms of energy. "One of ... the challenge of meeting the world population,s escalating need ...
Cached Biology News:American Physiological Society's latest conference focuses on integrative biology of exercise 2American Physiological Society's latest conference focuses on integrative biology of exercise 3Emory receives $20 million NSF grant for chemistry center 2Emory receives $20 million NSF grant for chemistry center 3Emory receives $20 million NSF grant for chemistry center 4Rice launches sweeping Energy and Environment Initiative 2Rice launches sweeping Energy and Environment Initiative 3Rice launches sweeping Energy and Environment Initiative 4Rice launches sweeping Energy and Environment Initiative 5
Mouse monoclonal antibody to UGT2B10 - UDP glucuronosyltransferase 2 family, polypeptide B10...
Mouse polyclonal antibody raised against a partial recombinant COASY. NCBI Entrez Gene ID = 80347...
... is intended for first-time users of the PROTEAN ... includes a protein sample and reagents sufficient to ... 17 cm, ten 11 cm, or sixteen 7 ... precast SDS-PAGE gels and gels stains are not ...
... Phosphate Phosphatase 2 (LPP2) ... aqueous solution Solution ... containing 0.08% sodium azide. ... the human LPP2 protein. ...
Biology Products: